Elevation Oncology Inc (NAS:ELEV)
$ 2.57 -0.205 (-7.41%) Market Cap: 140.42 Mil Enterprise Value: 67.18 Mil PE Ratio: 0 PB Ratio: 1.75 GF Score: 35/100

Elevation Oncology Inc Annual Shareholders Meeting Transcript

Jun 16, 2023 / 03:00PM GMT
Release Date Price: $1.47 (-0.68%)
Operator

Welcome to the Elevation Oncology Annual Meeting. Our host for today's call is Joe Ferra, Interim CEO, President, and CFO. At this time, all participants will be in a listen-only mode.

I will now turn the call over to your host, Mr. Ferra, you may begin, sir.

Joe Ferra
Elevation Oncology, Inc. - Interim CEO and CFO

Thank you. Good morning, ladies and gentlemen. I am Joe Ferra, Interim CEO, President, and CFO of Elevation Oncology. It is a pleasure to welcome you to our Annual Meeting of Stockholders. The meeting is now called to order.

I would also like to introduce the following members of the Board of Directors who are with us this morning: Mike Carruthers, Tim Clackson, Steve Elms, Lori Hu, Colin Walsh. I would also like to introduce our Chief Medical Officer, Dr. Valerie Jansen; our Chief Scientific Officer, David Dornan; and our Corporate Secretary, Robert Yang, who will be acting as Inspector of Election for this meeting. I will serve as Chairman of the meeting.

I also want to introduce Alex Castelli of CohnReznick LLP, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot